There are 2949 resources available
Invited Discussant 2O and 3O
Presenter: Vincent Dezentje
Session: Proffered Paper - Basic Science
Resources:
Webcast
Q&A and live discussion
Presenter: Daniel Peeper
Session: Proffered Paper - Basic Science
Resources:
Webcast
Invited Discussant 700O and 701O
Presenter: Walter Berger
Session: Proffered Paper - GU, non prostate 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Manuela Schmidinger
Session: Proffered Paper - GU, non prostate 2
Resources:
Webcast
Invited Discussant 702O and LBA25
Presenter: Laurence Albiges
Session: Proffered Paper - GU, non prostate 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Manuela Schmidinger
Session: Proffered Paper - GU, non prostate 2
Resources:
Webcast
Invited Discussant LBA31 and 805O
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Webcast
LBA6_PR - Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Presenter: Markus Moehler
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA7_PR - Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
Presenter: Narikazu Boku
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast